Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim Gullbo

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
BMC Research Notes|July 1, 2009
Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drugHenrik Lövborg, Robert Burman, Joachim Gullbo
Anti-Cancer Drugs|June 3, 2005
Screening for apoptosis--classical and emerging techniquesHenrik Lövborg, Joachim Gullbo, Rolf Larsson
BMC Cancer|July 9, 2013
Effects of hypoxia on human cancer cell line chemosensitivitySara Strese, Mårten Fryknäs, Rolf Larsson, et al.
Cancer Science|January 6, 2011
Aminopeptidase N (CD13) as a target for cancer chemotherapyMalin Wickström, Rolf Larsson, Peter Nygren, et al.
Anti-Cancer Drugs|September 30, 2009
Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cellsDaniel Laryea, Joachim Gullbo, Anders Isaksson, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 18, 2015
Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?Karthik Selvaraju, Magdalena Mazurkiewicz, Xin Wang, et al.
Anticancer Research|June 25, 2003
p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancerMichael Bergqvist, Daniel Brattström, Joachim Gullbo, et al.
Journal of Natural Products|March 24, 2007
Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranesErika Svangård, Robert Burman, Sunithi Gunasekera, et al.
BMC Research Notes|November 4, 2017
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cellsLinda Sooman, Joachim Gullbo, Michael Bergqvist, et al.
Biochemical Pharmacology|May 9, 2002
Modulation of pyridyl cyanoguanidine (CHS 828) induced cytotoxicity by 3-aminobenzamide in U-937 GTB cellsHenrik Lövborg, Petra Martinsson, Joachim Gullbo, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
BMC Research Notes|July 1, 2009
Structure-activity relationship analysis of cytotoxic cyanoguanidines: selection of CHS 828 as candidate drugHenrik Lövborg, Robert Burman, Joachim Gullbo
Anti-Cancer Drugs|June 3, 2005
Screening for apoptosis--classical and emerging techniquesHenrik Lövborg, Joachim Gullbo, Rolf Larsson
BMC Cancer|July 9, 2013
Effects of hypoxia on human cancer cell line chemosensitivitySara Strese, Mårten Fryknäs, Rolf Larsson, et al.
Cancer Science|January 6, 2011
Aminopeptidase N (CD13) as a target for cancer chemotherapyMalin Wickström, Rolf Larsson, Peter Nygren, et al.
Anti-Cancer Drugs|September 30, 2009
Characterization of the cytotoxic properties of the benzimidazole fungicides, benomyl and carbendazim, in human tumour cell lines and primary cultures of patient tumour cellsDaniel Laryea, Joachim Gullbo, Anders Isaksson, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|July 18, 2015
Inhibition of proteasome deubiquitinase activity: a strategy to overcome resistance to conventional proteasome inhibitors?Karthik Selvaraju, Magdalena Mazurkiewicz, Xin Wang, et al.
Anticancer Research|June 25, 2003
p53 status and its in vitro relationship to radiosensitivity and chemosensitivity in lung cancerMichael Bergqvist, Daniel Brattström, Joachim Gullbo, et al.
Journal of Natural Products|March 24, 2007
Mechanism of action of cytotoxic cyclotides: cycloviolacin O2 disrupts lipid membranesErika Svangård, Robert Burman, Sunithi Gunasekera, et al.
BMC Research Notes|November 4, 2017
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cellsLinda Sooman, Joachim Gullbo, Michael Bergqvist, et al.
Biochemical Pharmacology|May 9, 2002
Modulation of pyridyl cyanoguanidine (CHS 828) induced cytotoxicity by 3-aminobenzamide in U-937 GTB cellsHenrik Lövborg, Petra Martinsson, Joachim Gullbo, et al.
Pageof 8